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Detrusor underactivity (DU) is frequently encountered in elderly patients with chronic medical or
neurological diseases. DU causes chronic urinary retention or large postvoid residual urine that is usually
difﬁcult to manage. The pathophysiology of DU may involve neurogenic, myogenic, and bladder outlet
pathologies. Recent studies also reveal that urothelial dysfunction of the urinary bladder may be asso-
ciated with impaired bladder sensation as well as impaired detrusor contractility. This article reviews
recent research on the prevalence, pathophysiology, and clinical management of DU. Comprehensive
clinical investigations and basic research may provide a better understanding and effective treatment for
this common but difﬁcult bladder disorder.
Copyright © 2014, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Chronic urinary retention is a debilitating bladder disorder that
negatively impacts quality of life and also threatens health. Chronic
urinary retention is frequently encountered and is difﬁcult to
manage in elderly patients with chronic medical diseases, such as
diabetes mellitus (DM), and chronic heart failure or neurological
diseases, such as cerebrovascular accident, Parkinson's disease, and
dementia. Urinary tract infection (UTI) and renal function deterio-
rationwill develop if the bladder condition is not properlymanaged
with clean intermittent catheterization or an indwelling Foley
catheter. The pathophysiology of chronic urinary retention may
involve neurogenic, myogenic, and bladder outlet pathologies [1].
Recent studies have also revealed that urothelial dysfunction of the
urinary bladdermay be associated with impaired bladder sensation
as well as impaired detrusor contractility [2]. Furthermore, urethral
mucosal dysfunction and smooth muscle hyperactivity of the
bladder neck and the urethra might also play important roles in the
initiation of micturition. Research is needed to explore the
pathophysiology of detrusor underactivity (DU) and underactive
bladder (UAB).Buddhist Tzu Chi General
alien, Taiwan. Tel.: þ886
elief Tzu Chi Foundation. Publishe2. Deﬁnition of underactive bladder
The International Continence Society deﬁnes DU as a contrac-
tion of reduced strength and/or duration, resulting in prolonged
bladder emptying and/or failure to achieve complete bladder
emptying within a reasonable time [3]. Patients with UAB/DU
usually have a diminished sensation of bladder fullness or urgency
and cannot contract the detrusor sufﬁciently to complete bladder
emptying. Urodynamic study of UAB/DUmay be characterized by a
noncontractile detrusor, low pressure, or poorly sustained detrusor
contraction in association with a poor ﬂow rate with or without a
large post-void residual (PVR) volume [4]. Patients with UAB/DU
usually void with abdominal straining and an intermittent ﬂow
pattern is noted. The bladder sensation may be normal or reduced
in sensing a ﬁrst or urge sensation [5]. Some patients with UAB/DU
may have both detrusor hyperactivity and inadequate contractility
(DHIC), resulting in urgency incontinence and a large PVR [6]. In
patients with UAB/DU, the intrinsic detrusor contraction speed is
more compromised than intrinsic strength. Patients with UAB/DU
can be divided into the following three groups according to the
urodynamic ﬁndings: (1) low maximum detrusor contraction ve-
locity, low isovolumetric detrusor pressure, and bladder emptying
efﬁciency of <67%; (2) lowmaximum detrusor contraction velocity,
low isovolumetric detrusor pressure, and bladder emptying efﬁ-
ciency of67%; and (3) lowmaximum contraction velocity, normal
isovolumetric detrusor pressure, and bladder emptying efﬁciency
of 67% [7]. These urodynamic ﬁndings are also found in womend by Elsevier Taiwan LLC. All rights reserved.
Table 1
Prevalence of detrusor underactivity in women with lower urinary tract symptoms.
Normal ﬁndings 272 (16.9)
Sensory disorders (459)
 Bladder oversensitivity 289 (18.0)
 Suggestive of interstitial cystitis/painful bladder syndrome 170 (10.6)
Motor disorders (560)
 Idiopathic detrusor overactivity 308 (19.2)
 Detrusor hyperactivity and inadequate contractility 69 (4.3)
 Detrusor underactivity 183 (11.4)
Bladder outlet disorders (314)
 Bladder neck dysfunction 27 (1.7)
 Dysfunctional voiding 168 (10.5)
 Urethral stricture 17 (1.1)
 Poor relaxation of pelvic ﬂoor muscles 102 (6.4)
Data are presented as n (%).
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each group might be different and can be attributed to varying
detrusor muscle contractility and bladder outlet resistance in in-
dividual patients.
3. Prevalence of UAB/DU
UAB/DU is a common urological problem in elderly patients
presenting with urinary retention and lower urinary tract symp-
toms (LUTS). DU has been found in nearly two-thirds of incontinent
institutionalized elderly people [9]. The incidence and prevalence
of UAB/DU is highly dependent on the deﬁnition and the avail-
ability of diagnostic tests. In a retrospective study, 40.2% of men and
13.3% of women undergoing urodynamic study for LUTS were
classiﬁed as having DU [10]. In urodynamic evaluation of patients
with non-neurogenic LUTS, DU was found in 9e48% of men and
12e45% of older women [11]. One urodynamic pressure ﬂow study
revealed that 41% of elderlymenwith symptoms of difﬁcult bladder
emptying had an obstructive high pressure low ﬂow pattern, 28.2%
had an underactive detrusor contractility pattern, 20.5% had a
mixed obstructive and underactive detrusor type, and 10.3% had a
normal pattern [12]. The prevalence of bladder outlet obstruction
(BOO) voiding difﬁculty and DU in female urology patients who
visited several urology clinics in nine hospitals was 87.2% and 12.8%,
respectively [13]. Gotoh et al [14] found impaired detrusor
contraction in 81.9% and BOO in 14.8% of women with impaired
bladder emptying.
UAB/DU usually occurs in patients with spinal cord injury
(central neuropathy) or post pelvic surgery (peripheral neuropa-
thy). In 100 women with urinary retention, Sakakibara et al [15]
found the underlying diseases included multiple system atrophy,
multiple sclerosis, cervical/thoracic tumors, and lumbar spondy-
losis. DU is also common in older patients, in those with general
weakness and medical diseases such as DM, debilitating disease,
and cancer in the terminal stages, and after major surgery [16].
Women with diabetic voiding dysfunction were found to have a
longer duration of DM than those with an overactive bladder.
Ageing and UTI are two independent factors contributing to
impaired voiding function and diabetic bladder dysfunction [17]. A
large proportion of patients with diabetic cystopathy were found to
have electrophysiological (EP) evidence of neuropathy, which can
moderately predict the presence of cystopathy [18]. DM can affect
the bladder, presumably via peripheral pathogenetic mechanisms
that induce DHIC. Patients with DU showed impaired emptying
function and decreased sensation on cystometry and intravesical
current perception threshold testing [19].
UAB/DU and DHICwere also common (15% and 1%, respectively)
in patients with recent ischemic stroke [20]. Although UAB/DUmay
occur in any age group, both conditions have an age-associated
prevalence. The actual contribution of ageing on detrusor
contractility, however, has not been conclusively demonstrated. In
one study, UAB/DU was observed in 41% of patients presenting
with urinary incontinence or LUTS following radical prostatectomy
[21]. UAB/DU may be chronic or temporary. In clinical practice, we
have observed patients with BOO and normal detrusor contractility
who have developed transient UAB/DU after transurethral resec-
tion of the prostate or immediately after a minor stroke. These
patients may regain spontaneous voiding within 1e3 months.
However, some patients might develop chronic DU and sponta-
neous voiding may not return in the short term. There must be
some underlying pathogenesis for the development of transient
UAB/DU, such as detrusor muscle damage or neurological
inhibition, which interferes with the integration of musculo-
mucosal mechanoreceptors, mucosal mechanoreceptors, and che-
moreceptors [22].We have previously investigated videourodynamic characteris-
tics in men and women with LUTS refractory to conventional
medication. DUwas noted in 146 (5.2%) of 2,831menwith LUTS and
DHIC in 150 (5.3%) of 2,831 men with LUTS. The incidence of DHIC
increased with ageing; however, the incidence of DU with age was
not signiﬁcantly different from that in other vesicourethral dys-
functions such as detrusor overactivity, bladder neck dysfunction
and benign prostatic obstruction. DU was noted in 108 (36.1%) of
299 patients with a PVR >250 mL and DHIC in 44 (14.7%) of 299
patients with a PVR >250 mL. The bladder sensation of ﬁlling and
fullness were signiﬁcantly reduced compared with that in patients
with BOO. The incidence of DU in 1,333 female patients with LUTS
was 11.4% and DHIC was noted in 4.3% (Table 1). The medical co-
morbidity in 118 women presenting with chronic urinary retention
or a large PVR included DM (43, 30.7%), hypertension (52, 37.1%),
coronary arterial disease (17, 12.1%), chronic obstructive pulmonary
disease (3, 2.1%) and chronic kidney disease (25, 17.9%) [23].
4. Pathophysiology of UAB/DU
The pathogenesis of UAB/DU is likely to be multifactorial [1].
UAB/DU may be classiﬁed into myogenic and neurogenic mecha-
nisms [24]. The causes of UAB/DU include DM, BOO, ageing,
neurological diseases, spinal cord lesions, and pelvic plexus and
infectious neurological problems [25]. UAB/DU can result from
damage to the bladder afferent pathways, bladder efferent path-
ways, or lumbosacral spinal cord or be due to pure detrusor failure
[26]. There is a need for longitudinal patient data to deﬁne risk
factors, develop screening tools, and establish an animal model for
translational research into UAB/DU [27].
4.1. UAB/DU in patients with chronic urinary retention may be
caused by latent neuropathy
In videourodynamic study (VUDS), patients with chronic uri-
nary retention usually have low voiding pressure or DU without
signiﬁcant BOO, deﬁned as non-obstructive voiding dysfunction.
We retrospectively collected 60 patients, who were diagnosed with
nonobstructive voiding dysfunction on VUDS and had received
lower urinary tract EP studies. EP studies included examination of
the bulbocavernous reﬂex by electrical stimulation, electro-
metrography of the external urethral sphincter (EUS), and nerve
conduction velocity (NCV) study of the internal pudendal nerve. In
electrometrography study, denervation, reinnervation changes, and
reduced recruitment of the EUS was observed in 21.7%, 71.7%, and
86.7% of patients, respectively. Decreased amplitude of the internal
pudendal nerve was noted in NCV study in 73.3% of the patients.
Signiﬁcant sacral neuropathy (e.g., saddle anesthesia) was present
on neurological examination in 19 out of 60 patients (31.7%).
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positive rate (p ¼ 0.001), a non-signiﬁcant but higher denervation
rate (p ¼ 0.059) in electrometrography studies, and a higher rate of
decreased amplitude in NCV studies (p ¼ 0.011) than those without
sacral neuropathy. DU patients had a high percentage of neuro-
logical deﬁcits in EP studies. Reinnervation and reduced recruit-
ment of the EUS indicated that the lower urinary tract experienced
an incomplete or inadequate recovery from potential neurological
insults. Decreased amplitude in NCV studies also suggested the
presence of internal pudendal neuropathy. Potential neurological
insults explored in EP studies could play an important role in the
pathophysiology of DU, and EP studies may aid in the treatment
strategy of nonobstructive voiding dysfunction (including DU) in
the future.
4.2. UAB/DU due to detrusor failure or BOO
Diabetic cystopathy can occur silently early or late in the course
of DM. DM induces a decrease in detrusor contractility and in-
creases oxidative stress factors, resulting in urothelial dysfunction
or causing an alteration of the pathophysiology of detrusor muscle
cells, resulting in impaired bladder sensation or impaired detrusor
contractility [28]. BOO can result in structural and functional
changes in the bladder wall. Detrusor contractility may be reduced
in patients with chronic urinary retention or a large PVR due to
benign prostatic hyperplasia with BOO [29]. It is difﬁcult, however,
to differentiate idiopathic UAB/DU from chronic urinary retention
secondary to BOO. Patients with chronic BOOmight also have a low
detrusor pressure and a large PVR. In a minimum 10-year urody-
namic follow-up in men with BOO, there was no evidence to sug-
gest that detrusor contractility declined with long-term BOO.
Relieving the obstruction surgically did not improve detrusor
contractility. An underactive detrusor remained underactive, but
did not get worse with time [30].
In adult male patients with LUTS, detrusor contraction power
parameters, the bladder contractility index and themaximumwork
(W max) continuously increase with an increasing grade of BOO. We
were unable to determine a single threshold value for detrusor
contraction power to diagnose idiopathic DU (non-BOO DU) in a
group of LUTS patients with different grades of BOO [31]. The ul-
trastructural changes seen on electromicroscopic examination of
detrusor biopsies from DU bladders revealed approximately four
times more disruptive cells than in controls, which might interrupt
the electrical transmission between muscle cells and result in low
detrusor contractility on stimulation [32]. Passive bladder wall
stiffness in rats with spinal cord transection was signiﬁcantly
reduced compared with that in the sham-operated control group,
and spinal cord transection bladder strips relaxed more quickly
than those sham-operated rats. The reduced passive bladder wall
stiffness and enhanced rate of stress relaxation revealed that
increased compliance is marked by altered matrix properties that
dissipate muscle force, thereby generating low pressures [33].
Whether UAB/DU is a progressive change from DHIC remains un-
known, but the impairment of detrusor contractility with and
without altered bladder sensation might be the cause of UAB/DU
and DHIC in aging patients, respectively [5,34].
4.3. Impaired bladder sensation and UAB/DU
Normal bladder sensation and transduction of stretch (urothe-
lial pathway) are essential for normal micturition. Normal afferent
nerves convey the bladder sensations of ﬁlling, urgency, and noci-
ception via C-ﬁbers within the urothelium and suburothelium or A-
delta ﬁbers within the detrusor muscles. The sensory activation of
the micturition reﬂex is essential for normal detrusor contractilityon stimulation [6]. In patients with acute or chronic sensory
afferent nerve lesions (such as herpes zoster infection or syphilis-
induced tabes dorsalis), detrusor contractility is greatly impaired
and urinary retention may ensue.
The inhibitory effects of detrusor contraction by the striated
urethral sphincter and the bladder neck via alpha-adrenergic ac-
tivity may also play a role in the development of UAB/DU.
Furthermore, normal perception of bladder fullness and an urge
sensation are the fundamental bases for a normal micturition
process. Patients with severe cortical degenerative diseasemay lack
bladder perception and be unable to initiate voiding. Ageing can
cause structural and functional changes in the bladder afferent
nerves and detrusor power, and reﬂex activity might also be
impaired [5]. In addition, chronic BOO and latent cortical degen-
eration might also occur in elderly patients, especially when they
experience severe illness or major surgery, resulting in UAB/DU.
4.4. Urothelial dysfunction and UAB/DU
It is possible that bladder urothelial dysfunction, sensory nerve
dysfunction, and detrusor myogenic dysfunction e as well as
impaired central nervous system control e are involved, in part or
totally, in the development of UAB/DU. Understanding the patho-
physiology of UAB/DU in individual patients is the mainstay of
appropriate management.
The urothelium is not only a barrier to urine solutes but also
expresses various receptors and ion channels that are responsible
for mechanical or thermal changes in the bladder, such as receptors
to bradykinin, trkA, p75, purine (P2X and P2Y), noradrenaline
(alpha and beta adrenaline), and acetylcholine (muscarinic or
nicotinic) [35e43]. The urothelium also expresses several vanilloid
receptors, called transient receptor potential channels (TRPV1,
TRPV 2, TRPV4, TRPM8, and TRPA1), suggesting that urothelial cells
also exert a sensory function in bladder ﬁlling and noxious stimuli
[44e48]. Stimulation of these sensory receptors by mechanical
trauma, hydrostatic pressure changes, and chronic inﬂammation
can release chemicals such as adenosine triphosphate (ATP), pros-
taglandins, nerve growth factors (NGF), acetylcholine, and nitric
oxide (NO), which may have excitatory or inhibitory effects on the
afferent nerves or detrusor contractility [49e53]. Recent study
suggests that TRPV4 senses bladder urothelial cultured cell
stretching, which is converted to ATP signals in the micturition
reﬂex pathway during the storage phase [54]. Downregulation of
TRPV4 might lead to a decreased sensation of bladder fullness and
detrusor underactivity.
The urothelium might inﬂuence the contractile state of detru-
sor smooth muscles, through modifying its contractility and the
extent of spontaneous activity [2]. In one study, the ratio of ATP to
NO, representing sensory transmission in the bladder, was high in
a bladder model of overactive bladder and low in a bladder model
of UAB/DU. ATP release had a positive correlation whereas NO
release had a negative correlation with the bladder contraction
frequency. The urinary ATP/NO ratio may be a clinically relevant
biomarker that characterizes the extent of bladder dysfunction
[55]. In addition, bladder ischemia and repeated ischemia/reper-
fusion during a micturition cycle may produce oxidative stress,
leading to denervation and further tissue damage in the bladder
wall [56]. This ischemic effect on the bladder wall might be the
cause of transient urinary retention in patients after major surgery
or acute illness.
An intact bladder mucosa has been associated with an increase
in spontaneous contractile activity in whole-bladder preparations
[57]. The urothelium exerts an excitatory effect on the underlying
muscle whereas suburothelial tissue causes an inhibitory effect. It
was proposed that mucosal M3 receptors induce the release of a
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detrusor contractility [58]. A group of interstitial cells that have a
contractile phenotype and contain smooth muscle actin have been
found between the bladder mucosa and detrusor [59]. Interstitial
cells are the major site for the gap junction protein connexin 43
(Cx43), and allow propagation of electrical and calcium signals
across a functional syncytium [60]. Currently, interstitial cells are
believed to transmit signals from the urothelium or detrusor.
Impaired function of interstitial cells might cause impaired detru-
sor contractility through impaired bladder urothelial sensory input.
The number of interstitial cells and the density of Cx43 were found
to increase in an overactive bladder [61]. Whether the density of
Cx43 is decreased in the bladders of patients with UAB/DU has not
been elucidated. The density of interstitial cells in UAB/DU bladders
has also not been reported.
We investigated urothelial dysfunction in 37 patients with DU
and 20 healthy controls. In patients with DU, junction protein E-
cadherin was signiﬁcantly lower and suburothelial inﬂammation
determined by mast cell count and urothelial cell apoptosis were
signiﬁcantly higher than in controls. However, there was no sig-
niﬁcant difference in barrier protein zonula occludens-1 expression
between DU and controls (Table 2). These results indicate that
chronic inﬂammation and urothelial dysfunction are present in DU
bladders. These immunohistochemistry ﬁndings can only explain
that urothelial dysfunction is evident in patients with DU. We need
furthermolecular studies of functional receptors such as TRPV4 and
P2X3 to explore the possible pathomechanisms of UAB/DU. TRPV4
is a nonselective cation channel involved in different sensory
functions and was recently implicated in bladder mechanosensa-
tion. Immunoprecipitation experiments established a molecular
connection between TRPV4 and the adherence junctions of the
bladder mucosa [62]. The lower expression of E-cadherin may be
associated with decreased bladder sensation during mucosal
stretching.
Investigation of the expressions of urothelial sensory receptors
(P2X3, TRPV1, TRPV4, etc.), urothelial junction proteins (E-cad-
herin), chronic inﬂammation of the urothelium (tryptase, inducible
NO synthase, cyclooxygenase-2 etc), sensory nerve functional
proteins (NGF, prostaglandin E2 and NO), detrusor muscarinic M2
andM3 receptors, muscular junction protein (Cx43), and analysis of
apoptotic cell activities (terminal deoxynucleotidyl transferase
dUTP nick end labeling), might provide valuable information on the
pathophysiology of UAB/DU. In addition, using urine and serum
biomarkers tomeasure neuronal regeneration activity, such as NGF,
brain-derived neurotrophic factor and prostaglandin E2 will also be
helpful. Investigation of serum inﬂammatory proteins and cyto-
kines such as NGF, C-reactive protein, interleukin (IL)-1beta, IL-6,
IL-8, and IL-10 will also beneﬁt the understanding of the patho-
physiology of UAB/DU. Finally, study of urethral mucosal dysfunc-
tion including alpha-1 adrenoceptors and muscarinic receptor
density might also provide evidence of the underlying causes of
UAB/DU.Table 2
The differences in E-cadherin, mast cell count, urothelial cell apoptosis, and zonula
occludens-1 expression in detrusor underactivity and normal controls.
Normal Detrusor
underactivity
p
E-cadherin 38.41 ± 19.21 28.82 ± 18.12 0.001
Mast-cell 3.0 ± 2.83 10.81 ± 5.53 < 0.001
Terminal deoxynucleotidyl
transferase dUTP nick
end labeling
0.49 ± 0.99 6 ± 3.23 < 0.001
Zonula occludens-1 8.23 ± 4.99 7.74 ± 3.37 0.6934.5. Role of the bladder neck and urethral sphincter hyperactivity in
UAB/DU
Detrusor, bladder neck, and urethral sphincter dysfunction are
usually characterized as motor neuron diseases because their fea-
tures correspond to damage to the spinal cord or cauda equina,
which involves the somatic and parasympathetic pathways [63].
Afferent nerves of the pudendal nerve are postulated to have a
potential modulatory effect on sympathetic neuronal control in
various neuropathic and non-neuropathic bladder dysfunctions,
but the mechanisms and pathways remain unknown [64]. Bladder
neck dysfunction seems to represent sympathetic hyperactivity or
dysfunction and poor accommodation, which are considered to be
secondary to abnormal adrenergic detrusor innervation [65].
Clinically, transurethral incision of the bladder neck (TUI-BN) not
only disrupts the continuity of a tight bladder neck but might also
abolish the inhibitory effect on detrusor contractility [66]. Patients
with idiopathic DU may regain adequate detrusor contractility and
resume spontaneous voiding [67,68]. Decreased urethral pressure
by preganglionic pelvic nerve stimulation and the administration of
alpha- and beta-methylene ATP in female pigs also resulted in
bladder detrusor contractions [69]. A poorly relaxed urethral
sphincter is thought to cause increased urethral afferent activity,
which inhibits bladder afferent signaling leading to poor bladder
sensation and UAB/DU. The application of sacral neuromodulation
in patients with Fowler's syndrome can therefore restore normal
voiding [70]. Patients with stroke and incomplete bladder
emptying might also develop UAB/DU due to spasticity of the
external sphincter [71]. Bladder neck dysfunction, dysfunctional
voiding, and DU are the main urodynamic abnormalities in young
men with LUTS [72,73]. Treatment targeting bladder or urethral
sphincter hyperactivity might restore normal detrusor contractility
and improve voiding efﬁciency in patients without BOO who have
incomplete bladder emptying.
5. Clinical investigations of UAB/DU
Clinical investigation of patients with UAB/DU or DHIC should
be very comprehensive. A history and detailed physical examina-
tion including neurological examination should be carried out.
There should be a careful search for medical diseases that waste
body energy or local diseases that cause poor relaxation of the
pelvic ﬂoor muscles. Other examinations should include: urody-
namic pressure ﬂow study to test bladder sensory function, bladder
compliance, and detrusor contractility, as well as external sphincter
electrometrography coordination; VUDS to exclude possible
bladder outlet obstruction; and electrophysiology study to test for a
normal micturition reﬂex circuit, normal pudendal nerve conduc-
tion, and normal urethral sphincter electrometrography activity.
6. Treatment of UAB/DU
The treatment goal for UAB/DU is focused on reducing the PVR
and preventing UTI. Treatment of UAB/DU may include increasing
detrusor contractility, decreasing bladder outlet resistance, or
increasing the cortical perception of bladder sensation. However,
medical treatment for UAB/DU is usually disappointing. Para-
sympathomimetic agents and acetylcholinesterase inhibitors, with
or without alpha-blockers, might beneﬁt patients with DU [74e76].
Cholinesterase inhibitors might inhibit the degradation of acetyl-
choline and provide beneﬁcial effects in patients with UAB/DU.
These pharmacological treatments might not be suitable for pa-
tients with DHIC, however, as pharmacological treatment can
exacerbate overactive symptoms. Decreasing bladder outlet resis-
tance has been considered effective in reducing the PVR and
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are lacking to prove its efﬁcacy. In addition to pharmacological
treatment, percutaneous tibial nerve stimulation and intravesical
electrical stimulation have been effective for non-neurogenic, re-
fractory lower urinary tract dysfunction in children [77,78].
We performed TUI-BN to decrease bladder outlet resistance in
patients with UAB/DU [67]. A total of 46 patients with bladder neck
dysfunction underwent TUI-BN to relieve LUTS. Compared with
baseline data, postoperative VUDS revealed that the detrusor
pressure at the maximum ﬂow rate (Pdet$Qmax) decreased in 28
patients and increased in 12 patients, with persistent DU in six
individuals. The Pdet$Qmax increased signiﬁcantly from
8.7 ± 9.8 cmH2O to 28.3 ± 13.8 cmH2O (p ¼ 0.021) in patients with
low detrusor contractility or DU before the operation. Four (67%) of
the six patients with DU could void with the aid of abdominal
pressure after TUI-BN. Interestingly, some patients recovered
detrusor contractility after the surgical procedure. This phenome-
non has been observed not only in neurogenic bladders but also in
non-neurogenic DU [66,68], suggesting a micturition facilitating
reﬂexmight be triggered after TUI-BN. A total of 31 womenwith DU
and failed medical treatment underwent TUI-BN and were retro-
spectively studied. The patients with a postoperative voiding efﬁ-
ciency of >67% had excellent outcomes, those with 33e66%
efﬁciency hadmoderate results, and thosewith<33% efﬁciency had
poor surgical outcomes. The PVR, voiding efﬁciency, and Qmax
signiﬁcantly improved after TUI-BN. The PVR decreased by 56.3%
overall. Intermittent catheterization was needed in 27 patients
before surgery and in only seven patients after TUI-BN. Among the
17 patients with urodynamic DU prior to TUI-BN, six (35.3%)
regained detrusor contractility after the operation. There were 14
(45.2%) patients, 11 (35.5%) patients, and six (19.3%) patients with
excellent, moderate, and poor surgical outcomes, respectively [68].
The study suggested that TUI-BN is an effective procedure to
improve the PVR, Qmax, and voiding efﬁciency in women with DU
and urine retention.
It is also possible that the inhibitory effect of adrenergic hyperac-
tivity on detrusor contractility can be modulated after TUI-BN,
resulting in a recovery of detrusor function that has been inhibited
through unknown mechanisms. A recent clinical study showed that
78.9%ofpatientswithanacontractile bladderhadsigniﬁcant returnof
detrusor contractility after laser enucleation of the prostate [79].
Because theprostaticurethra is innervatedmainlyby thesympathetic
adrenergic nerves, ablation of the prostatic urethramight abolish the
sympathetic hyperactivity that inhibits detrusor contractility.References
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